Health, service and customer focus are our basic principles.
Vision
We are convinced that customers will have a long-term trusting relationship with the medical technology company Erib Ltd.
Mission
Erib Ltd. enables people to make their own choices about their health with WeLoxx
Objectives
The entrepreneurial thinking from Erib Ltd, with highly transparent answer and WeLoxx aim to battle against obesity. Customized solutions for critical periods will be prepared and used.
The team is prepared for this task, and is flexible and cooperative in every case.
Strategy
Our strategy is concentrated on a long-term trust with customers, and a relationship in which we offer clear solutions.
History
Since the foundation in 2010, our activities have been grounded in the medical related business of biomedical technology. Erib® Ltd was originally funded by two institutional investors. Our medical technology company, with its
own developed microtechnology product seeks national and international trade in connection with Erib med-center
© Copyright 2008 Erib Corp., Switzerland, All Rights
reserved - Logos, Brandnames and Models are protected by their respective
Right Holders Impressum; AGB; Terms_&_Conditions: EU-GDPR This website contains information on products which is
targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your
country. Please be aware that we do not take any responsibility for accessing such information which
may not comply with any legal process, regulation, registration or usage
in the country of your origin. We don't have at today's time from all site owners a
written authorization for to show all links on this website. The shown and/or not
shown(to be under development or to be in preparation) clinical trials are use neither in ascending nor indescending line complete extant. Regulation: https://gdpr-info.eu - Our ompany(ies) are subject to GDPR and its legal basis and apply it accordingly - 25.05.2018
powered by erib corp., Switzerland
- the additional web application division Update 2018
|
|